120 related articles for article (PubMed ID: 35994794)
1. Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database.
Franko J; Yin J; Adams RA; Zalcberg J; Fiskum J; Van Cutsem E; Goldberg RM; Hurwitz H; Bokemeyer C; Kabbinavar F; Curtis A; Meyers J; Chibaudel B; Yoshino T; de Gramont A; Shi Q;
Eur J Cancer; 2022 Oct; 174():142-152. PubMed ID: 35994794
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.
van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M
Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
Franko J; Shi Q; Meyers JP; Maughan TS; Adams RA; Seymour MT; Saltz L; Punt CJA; Koopman M; Tournigand C; Tebbutt NC; Diaz-Rubio E; Souglakos J; Falcone A; Chibaudel B; Heinemann V; Moen J; De Gramont A; Sargent DJ; Grothey A;
Lancet Oncol; 2016 Dec; 17(12):1709-1719. PubMed ID: 27743922
[TBL] [Abstract][Full Text] [Related]
4. Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program.
Lieu CH; Renfro LA; de Gramont A; Meyers JP; Maughan TS; Seymour MT; Saltz L; Goldberg RM; Sargent DJ; Eckhardt SG; Eng C;
J Clin Oncol; 2014 Sep; 32(27):2975-84. PubMed ID: 25002720
[TBL] [Abstract][Full Text] [Related]
5. Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database.
Renfro LA; Goldberg RM; Grothey A; Sobrero A; Adams R; Seymour MT; Heinemann V; Schmoll HJ; Douillard JY; Hurwitz H; Fuchs CS; Diaz-Rubio E; Porschen R; Tournigand C; Chibaudel B; Hoff PM; Kabbinavar FF; Falcone A; Tebbutt NC; Punt CJA; Hecht JR; Souglakos J; Bokemeyer C; Van Cutsem E; Saltz L; de Gramont A; Sargent DJ;
J Clin Oncol; 2017 Jun; 35(17):1929-1937. PubMed ID: 28414610
[TBL] [Abstract][Full Text] [Related]
6. Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database.
Shi Q; de Gramont A; Grothey A; Zalcberg J; Chibaudel B; Schmoll HJ; Seymour MT; Adams R; Saltz L; Goldberg RM; Punt CJ; Douillard JY; Hoff PM; Hecht JR; Hurwitz H; Díaz-Rubio E; Porschen R; Tebbutt NC; Fuchs C; Souglakos J; Falcone A; Tournigand C; Kabbinavar FF; Heinemann V; Van Cutsem E; Bokemeyer C; Buyse M; Sargent DJ
J Clin Oncol; 2015 Jan; 33(1):22-8. PubMed ID: 25385741
[TBL] [Abstract][Full Text] [Related]
7. Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review.
Shen C; Tannenbaum D; Horn R; Rogers J; Eng C; Zhou S; Johnson B; Kopetz S; Morris V; Overman M; Parseghian C; Chang GJ; Lopez-Olivo MA; Kanwal R; Ellis LM; Dasari A
JAMA Netw Open; 2022 May; 5(5):e2213588. PubMed ID: 35608860
[TBL] [Abstract][Full Text] [Related]
8. Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database.
Renfro LA; Loupakis F; Adams RA; Seymour MT; Heinemann V; Schmoll HJ; Douillard JY; Hurwitz H; Fuchs CS; Diaz-Rubio E; Porschen R; Tournigand C; Chibaudel B; Falcone A; Tebbutt NC; Punt CJ; Hecht JR; Bokemeyer C; Van Cutsem E; Goldberg RM; Saltz LB; de Gramont A; Sargent DJ; Lenz HJ
J Clin Oncol; 2016 Jan; 34(2):144-50. PubMed ID: 26503203
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer.
Walter V; Jansen L; Hoffmeister M; Ulrich A; Roth W; Bläker H; Chang-Claude J; Brenner H
Am J Clin Nutr; 2016 Oct; 104(4):1110-1120. PubMed ID: 27581471
[TBL] [Abstract][Full Text] [Related]
11. Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.
Goldberg RM; Adams R; Buyse M; Eng C; Grothey A; André T; Sobrero AF; Lichtman SM; Benson AB; Punt CJA; Maughan T; Burzykowski T; Sommeijer D; Saad ED; Shi Q; Coart E; Chibaudel B; Koopman M; Schmoll HJ; Yoshino T; Taieb J; Tebbutt NC; Zalcberg J; Tabernero J; Van Cutsem E; Matheson A; de Gramont A
J Natl Cancer Inst; 2022 Jun; 114(6):819-828. PubMed ID: 34865086
[TBL] [Abstract][Full Text] [Related]
12. A paradox between preoperative overweight/obesity and change in weight during postoperative chemotherapy and its relationship to survival in stage Ⅱ and Ⅲ colorectal cancer patients.
Hu C; Zhang Q; Jin X; Zhang L; Zhang Y; Zhu Q; Tang M; Lyv G; Shi H
Clin Nutr; 2021 Apr; 40(4):2410-2419. PubMed ID: 33183882
[TBL] [Abstract][Full Text] [Related]
13. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
[TBL] [Abstract][Full Text] [Related]
14. Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.
Aparicio T; Ducreux M; Faroux R; Barbier E; Manfredi S; Lecomte T; Etienne PL; Bedenne L; Bennouna J; Phelip JM; François E; Michel P; Legoux JL; Gasmi M; Breysacher G; Rougier P; De Gramont A; Lepage C; Bouché O; Seitz JF;
Eur J Cancer; 2018 Jul; 98():1-9. PubMed ID: 29807237
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature.
Lombardi P; Rossini D; Crespi V; Germani MM; Bergamo F; Pietrantonio F; Santini D; Allegrini G; Daniel F; Pagani F; Antoniotti C; Zaniboni A; Conca V; Latiano TP; Boccaccino A; Passardi A; Tamburini E; Masi G; Di Maio M; Cremolini C
Cancer Treat Rev; 2022 Feb; 103():102326. PubMed ID: 35016085
[TBL] [Abstract][Full Text] [Related]
16. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.
Franko J; Shi Q; Goldman CD; Pockaj BA; Nelson GD; Goldberg RM; Pitot HC; Grothey A; Alberts SR; Sargent DJ
J Clin Oncol; 2012 Jan; 30(3):263-7. PubMed ID: 22162570
[TBL] [Abstract][Full Text] [Related]
17. [Integration Process of Clinical Trial Data in ARCAD-Asia].
Bando H; Takeda Y; Misumi T; Suzuki M; Wakabayashi M; Ohtsu A; Yoshino T
Gan To Kagaku Ryoho; 2023 Oct; 50(10):1021-1026. PubMed ID: 38035827
[TBL] [Abstract][Full Text] [Related]
18. Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database.
Margalit O; Harmsen WS; Shacham-Shmueli E; Voss MM; Boursi B; Wagner AD; Cohen R; Olswold CL; Saltz LB; Goldstein DA; Hurwitz H; Tebbutt NC; Kabbinavar FF; Adams RA; Chibaudel B; Grothey A; Yoshino T; Zalcberg J; de Gramont A; Shi Q; Lenz HJ
Eur J Cancer; 2023 Jan; 178():162-170. PubMed ID: 36446161
[TBL] [Abstract][Full Text] [Related]
19. Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
Hess LM; Barakat R; Tian C; Ozols RF; Alberts DS
Gynecol Oncol; 2007 Nov; 107(2):260-5. PubMed ID: 17675142
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
Yin J; Cohen R; Jin Z; Liu H; Pederson L; Adams R; Grothey A; Maughan TS; Venook A; Van Cutsem E; Punt C; Koopman M; Falcone A; Tebbutt NC; Seymour MT; Bokemeyer C; Rubio ED; Kaplan R; Heinemann V; Chibaudel B; Yoshino T; Zalcberg J; Andre T; De Gramont A; Shi Q; Lenz HJ
J Natl Cancer Inst; 2021 Nov; 113(12):1705-1713. PubMed ID: 34061178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
